US Patent 8093356 Pegylated human interferon polypeptides
Patent 8093356 was granted and assigned to Ambrx on January, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+186 characters)
Article
Patent abstract
Modified human interferon polypeptides and uses thereof are provided, including PEGylated human interferon polypeptides with one or more non-naturally encoded amino acids.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08093356 Pegylated human interferon polypeptides US Patent 8093356 Pegylated human interferon polypeptides
Infobox
Patent Number
0809335600
Patent Number
809335600
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080933560
Date of Patent
January 10, 2012
0Patent Application Number
119253370
Date Filed
October 26, 2007
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080933560
Date of Patent
January 10, 2012
0Patent Application Number
119253370
Date Filed
October 26, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08093356 Pegylated human interferon polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08093356
Date of patent
January 10, 2012
Patent application number
11925337
Date Filed
October 26, 2007
Patent primary examiner
Find more entities like US Patent 8093356 Pegylated human interferon polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
